Back to SNDX

Kynam Capital Management, LP → SNDX

Kynam Capital Management, LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$153.2M
Q3 2026
Peak value
$188.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$169.2M
Q1 2026$188.1M
Q2 2026$176M
Q3 2026$153.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$153.2M8.15M——
Q2 2026$176M8.05M——
Q1 2026$188.1M8.05M——
Q4 2025$169.2M8.05M——

Other funds holding SNDX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M
PCVX

VAXCYTE INC

$169.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$164.2M